Molecular Therapy

SAN DIEGO — The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than reported in prior clinical trials, according to study results.

Healio spoke with Naval Daver, MD, about presentations on the use of molecular therapies, including menin inhibitors, in the treatment of acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Accurate risk stratification during the immediate perioperative period that incorporates molecular theranostics can help better guide decision-making for thyroid cancer treatment, according to a new joint statement published in Thyroid.

Neetu Gupta, PhD, associate professor at Cleveland Clinic Foundation, discussed exciting CAR-T presentations featured at the ASH Annual Meeting and Exposition, including new targets for lymphoid malignancies and CAR modifications to improve safety.